T cell costimulation by derivatives of benzoic acid

Antiviral Chemistry and Chemotherapy

Volumn 8, Issue 2, 1997, Pages 121-130

  Kinchington, D ^a   Ng, T ^a   Mathews, N ^a   Tisdale, M ^b   Devine, D ^a   Ayuko, W O ^b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b ASTON UNIVERSITY   (United Kingdom)

Author keywords

costimulation; HIV; immune dysregulation; immunodeficiency; immunomodulator; signal transduction

Indexed keywords

BENZOIC ACID DERIVATIVE;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOMODULATION; IN VITRO STUDY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0031059382     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029700800206     Document Type: Article

References (16)

1. Ayuko WO (1991). Free radicals as potential antitumour agents. DPhil thesis, Aston University, Birmingham, UK.
2. Good L, Maggirwar SB & Sun SC (1996). Activation of the IL-2 gene promoter by HTLV-1 Tax involves induction of NF-AT complexes bound to the CD28-responsive element. EMBO Journal 15: 3744-3750.
3. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM & Markowitz M (1995). Rapid turnover of plasma virion and CD4+ lymphocytes in HIV-1 infection. Nature 373: 123-126.
4. June CH, Bluestone JA, Nadler LM & Thompson CB (1994). The B7 and CD28 receptor families. Immunology Today 15: 321-331.
5. Kavanagh TJ, Grossmann A, Jinneman JC, Kanner SB, White CC, Eaton DL, Ledbetter JA & Rabinovitch PS (1993). The effect of 1-chloro-2,4-dinitrobenzene exposure on antigen receptor (CD3)-stimulated transmembrane signal transduction in purified subsets of human peripheral blood lymphocytes. Toxicology and Applied Pharmacology 119: 91-99.
6. Kinchington D, Galpin SA, O'Connor TJ, Jeffries DJ & Williamson JD (1989) Comparison of antigen capture assays against HIV-1 in evaluating antiviral compounds. AIDS 3: 101-104.
7. Kinchington D & NgT (1997). Separation and maintenance of primary T and B lymphocytes. In Animal Cell Culture. Edited by Walker JM and Pollard JW. New Jersey, USA: Humana Press, (in press).
8. Klein MR, van Baalen CA, Holwerda AM, Kerkof Garde SR, Bende RJ, Keet IP, Eeftinck-Schattenkerk JK, Osterhaus AD, Schuitemaker H & Miedema F (1995). Kinetics of gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. Journal of Experimental Medicine 181: 1365-1372.
9. Poli G & Fauci AS (1992). The effect of cytokines and pharmacologic agents on chronic HIV infection. AIDS Research and Human Retroviruses 8: 191-197.
10. Levine BL, Mosca JD, Riley JL, Carroll RG, Vahey MT, Jagodzinski LL, Wagner KF, Mayers DL, Burke DS, Weislow OS, St Louis DC & June CH (1996). Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation. Science 272: 1939-1943.
11. Ressler S, Connor LM & Marriott SJ (1996). Cellular transformation by human T-cell leukaemia virus type 1. FEMS Microbiology Letters 140: 99-100.
12. Rhodes J, Hen H, Hall SR, Joe DC, Colleens P & Geeing B (1995). Therapeutic potentiation of the immune system by co-stimulatory Schiff-base-forming drugs. Nature 377: 71-75.
13. Roberts NA, Martin JA, Kinchington D, Broadhurst AV, Craig JC, Duncan IB, Galpin SA, Handa BK, KayJ, Krohn A, Lambert RW, Merrett JH, Mills JS, Parks KEB, Redshaw S, Ritchie AJ, Taylor DL, Thomas GJ & Machin P (1990). Rational design of peptide-based HIV proteinase inhibitors. Science 248: 358-361.
14. Salahuddin SZ, Markham PD, Wong-Staal F, Franchini G, Kalyanaraman VS & Gallo RC (1983). Restricted expression of human T-cell leukemic lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology 129: 51-64.
15. Stricker RB, Zhu YS, Elswood BF, Dumlao C, Van Elk J, Berger TG, Tappero J, Epstein WL & Kiprov DD (1993). Pilot study of topical dinitrochlorobenzene (DNCB) in human immunodeficiency virus infection. Immunology Letters 36: 1-6.
16. Weissman D, Barker TD & Fauci AS (1996). The efficiency of acute infection of CD4+ T cells is markedly enhanced in the setting of antigen-specific immune activation. Journal of Experimental Medicine 183: 687-692.